Stocks · Health care · Pharmaceutical Preparations

Travere Therapeutics, Inc.

TVTX Clue Score50
United States Fiscal year ends December CIK 0001438533 Results filed 2 Nov 2026

What the insiders did Mostly scheduled

Insider
Date
Role
Action
Shares
Price
Amount
Timothy Coughlin
15 May 2026
Director
Sold on a plan
3,250
$43.49
$141.34K
Christopher R. Cline
6 May 2026
Chief Financial Officer
Sold on a plan
310
$43.95
$13.62K
Eric M Dube
6 May 2026
Chief Executive Officer
Sold on a plan
22,500
$43.95
$988.88K
Jula Inrig
6 May 2026
Chief Medical Officer
Sold on a plan
311
$43.95
$13.67K
Elizabeth E Reed
6 May 2026
Chief Legal Officer and GC
Sold on a plan
2,076
$43.95
$91.24K
William E. Rote
6 May 2026
Chief Research Officer
Sold on a plan
2,763
$43.95
$121.43K
Christopher R. Cline
5 May 2026
Chief Financial Officer
Sold on a plan
2,181
$46.65
$101.74K
Jula Inrig
5 May 2026
Chief Medical Officer
Sold on a plan
2,174
$46.65
$101.42K
Elizabeth E Reed
5 May 2026
Chief Legal Officer and GC
Sold on a plan
2,174
$46.65
$101.42K
William E. Rote
22 Apr 2026
Chief Research Officer
Sold on a plan
9,100
$39.09
$355.72K
Jula Inrig
15 Apr 2026
Chief Medical Officer
Sold on a plan
1,018
$42.61
$43.38K
Christopher R. Cline
15 Apr 2026
Chief Financial Officer
Sold on a plan
1,014
$42.61
$43.21K
Elizabeth E Reed
15 Apr 2026
Chief Legal Officer and GC
Sold on a plan
1,559
$42.53
$66.30K
Elizabeth E Reed
15 Apr 2026
Chief Legal Officer and GC
Sold on a plan
5,226
$41.62
$217.51K
Eric M Dube
15 Apr 2026
Chief Executive Officer
Sold on a plan
20
$42.66
$853.20
Eric M Dube
15 Apr 2026
Chief Executive Officer
Sold on a plan
7,165
$41.75
$299.14K
Eric M Dube
15 Apr 2026
Chief Executive Officer
Sold on a plan
56,815
$41.01
$2.33M
Jula Inrig
14 Apr 2026
Chief Medical Officer
Sold on a plan
7,215
$41.93
$302.52K
Christopher R. Cline
14 Apr 2026
Chief Financial Officer
Sold on a plan
7,239
$41.93
$303.52K
Christopher R. Cline
14 Apr 2026
Chief Financial Officer
Sold on a plan
9
$41.07
$369.63
Christopher R. Cline
13 Apr 2026
Chief Financial Officer
Sold on a plan
65
$28.85
$1.88K
Elizabeth E Reed
4 Feb 2026
Chief Legal Officer and GC
Sold on a plan
509
$32.74
$16.66K
Elizabeth E Reed
4 Feb 2026
Chief Legal Officer and GC
Sold on a plan
2,485
$32.07
$79.69K
Christopher R. Cline
4 Feb 2026
Chief Financial Officer
Sold on a plan
110
$32.90
$3.62K
Christopher R. Cline
4 Feb 2026
Chief Financial Officer
Sold on a plan
1,635
$32.14
$52.55K
Jula Inrig
4 Feb 2026
Chief Medical Officer
Sold on a plan
232
$32.85
$7.62K
Jula Inrig
4 Feb 2026
Chief Medical Officer
Sold on a plan
1,547
$32.11
$49.67K
William E. Rote
3 Feb 2026
Chief Research Officer
Sold on a plan
12,446
$32.87
$409.10K
Eric M Dube
3 Feb 2026
Chief Executive Officer
Sold on a plan
33,635
$32.70
$1.10M
Eric M Dube
3 Feb 2026
Chief Executive Officer
Sold on a plan
66,452
$32.06
$2.13M
Jula Inrig
6 Jan 2026
Chief Medical Officer
Sold on a plan
445
$37.75
$16.80K
Jula Inrig
5 Jan 2026
Chief Medical Officer
Sold on a plan
2,031
$40.18
$81.61K
Sandra Calvin
24 Dec 2025
SVP, Chief Accounting Officer
Sold on a plan
7,402
$40.00
$296.08K
Peter Heerma
24 Dec 2025
Chief Commercial Officer
Sold on a plan
4,980
$40.00
$199.20K
Sandra Calvin
15 Dec 2025
SVP, Chief Accounting Officer
Sold on a plan
2,910
$36.00
$104.76K

What was left out

Form 4 filings counted 69
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 35
Sales straight out of an exercise 75
Sales at will 8
Transactions with no price 0
Shares from compensation/vesting 2,184,722
History held since 26 Dec 2012